InsidersTradesSigma
Follow the PharmaCyte Biotech, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was reported on 12 December 2025 (Attribution). Among the most active insiders: WEINSTEIN ROBERT. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations